September 17, 2019

Associated Press: Many Commercially Marketed CBD Products Tainted With Psychoactive Adulterants

Commercially marketed CBD-infused products are not subject to explicit federal regulations. As a result, third-party lab testing has frequently revealed inconsistencies between the percentage of CBD advertised and the amount actually contained in some of these products.
September 16, 2019

NORML Members Take DC by Storm

Last week, NORML leaders and activists from across North America headed to our nation’s capital for the annual NORML Conference and Congressional Lobby Day.
September 16, 2019

Texas NORML Team Advocates in DC

This year the Texas delegation at the 2019 NORML Conference and Lobby Day grew exponentially! We had a group of seven advocates that made the trip up to Washington, DC.
September 13, 2019

Cannabis Vaping Concerns Call for Increased Regulations and Oversight

Rather than use these unfortunate incidents as an opportunity to further drive these markets into the shadows, the administration should officially legalize cannabis and empower the FDA to better study, regulate, and oversee these emerging THC and CBD delivery devices -- and to create regulatory standards for legal states to follow and enforce.